Developmental programming of cardiovascular disease by prenatal hypoxia

Journal of Developmental Origins of Health and Disease

Volumn 4, Issue 5, 2013, Pages 328-337

  Giussani, D A ^a   Davidge, S T ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

fetal hypoxia; interventions; Key words cardiovascular dysfunction; metabolic syndrome; treatment

Indexed keywords

EID: 84883404342     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S204017441300010X     Document Type: Review

References (128)

1. World Health Organization (WHO). World Health Statistics, 2012. World Health Organization: Geneva, Switzerland. ISBN 978 92 4 156444 1.
2. European Heart Network and European Society of Cardiology. European Cardiovascular Disease Statistics, 2012. European Heart Network and European Society of Cardiology: Brussels, Belgium. ISBN 978-2-9537898-1-2.
3. Conference Board of Canada. The Canadian Heart Health Strategy: Risk Factors and Future Cost Implications, 2010. Report, February 2010.
4. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011; 123, 933-944.
5. Agarwal A, Williams GH, Fisher NDL. Genetics of human hypertension. Trends Endocrin Metab (Review). 2005; 16, 127-133.
6. Barker DJP. Mothers, Babies and Disease in Later Life, 1994. BMJ Publishing Group: London.
7. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008; 359, 61-73.
8. Barker DJP, Osmond C, Winter PD, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet. 1989; 577-580.
9. Rich-Edwards JW, Stampfer MJ, Manson JE, et al. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ. 1997; 315, 396-400.
10. Leon D, Lithell HO, Vagero D, et al. Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15000 Swedish men and women born 1915-29. BMJ. 1998; 317, 241-245.
11. Fall CHD, Stein CE, Kumaran K, et al. Size at birth, maternal weight, and non-insulin dependent diabetes in South India. Diabet Med. 1998; 15, 220-227.
12. Huang RC, Mori TA, Beilin LJ. Early life programming of cardiometabolic disease in the Western Australian pregnancy cohort (Raine) study. Clin Exp Pharmacol Physiol. 2012; 39, 973-978.
13. Levitt NS, Lambert EV. The foetal origins of the metabolic syndrome-a South African perspective. Cardiovasc J S Afr. 2002; 13, 179-180.
14. Silva AA, Santos CJ, Amigo H, et al. Birth weight, current body mass index, and insulin sensitivity and secretion in young adults in two Latin American populations. Nutr Metab Cardiovasc Dis. 2012; 22, 533-539.
15. Roseboom TJ, van der Meulen JH, Ravelli AC, et al. Blood pressure in adults after prenatal exposure to famine. J Hypertens. 1999; 17, 325-330.
16. Eskenazi B, Marks AR, Catalano R, Bruckner T, Toniolo PG. Low birth weight in New York City and upstate New York following the events of September 11th. Hum Reprod. 2007; 22, 3013-3020.
17. Dalziel SR, Walker NK, Parag V, et al. Cardiovascular risk factors after exposure to antenatal betamethasone: 30-year follow-up of a randomised controlled trial. Lancet. 2005; 365, 1856-1862.
18. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev. 2005; 85, 571-633.
19. Seckl JR, Meaney MJ. Glucocorticoid programming. Ann N Y Acad Sci. 2004; 1032, 63-84.
20. Koos BJ. Adenosine A2a receptors and O2 sensing in development. Am J Physiol Regul Integr Comp Physiol. 2011; 301, R601-R622.
21. Giussani DA, Phillips PS, Anstee S, Barker DJ. Effects of altitude versus economic status on birth weight and body shape at birth. Pediatr Res. 2001; 49, 490-494.
22. Moore LG, Charles SM, Julian CG. Humans at high altitude: hypoxia and fetal growth. Respir Physiol Neurobiol. 2011; 178, 181-190.
23. Cohn HE, Sacks EJ, Heymann MA, Rudolph AM. Cardiovascular responses to hypoxemia and acidemia in fetal lambs. Am J Obstet Gynecol. 1974; 120, 817-824.
24. Boyle D, Hirst K, Zerbe G, Meschia G, Wilkening R. Fetal hind limb oxygen consumption and blood flow during acute graded hypoxia. Pediatr Res. 1990; 28, 94-100.
25. Giussani DA, Spencer JA, Moore PJ, Bennet L, Hanson MA. Afferent and efferent components of the cardiovascular reflex responses to acute hypoxia in term fetal sheep. J Physiol. 1993; 461, 431-449.
26. Jones CT, Robinson RO. Plasma catecholamines in foetal and adult sheep. J Physiol. 1975; 248, 15-33.
27. Fletcher AJ, Edwards CM, Gardner DS, Fowden AL, Giussani DA. Neuropeptide Y in the sheep fetus: effects of acute hypoxemia and dexamethasone during late gestation. Endocrinology. 2000; 141, 3976-3982.
28. Perez R, Espinoza M, Riquelme R, Parer JT, Llanos AJ. Arginine vasopressin mediates cardiovascular responses to hypoxemia in fetal sheep. Am J Physiol Regul Integr Comp Physiol. 1989; 256, R1011-R1018.
29. Morrison S, Gardner DS, Fletcher AJ, Bloomfield MR, Giussani DA. Enhanced nitric oxide activity offsets peripheral vasoconstriction during acute hypoxaemia via chemoreflex and adrenomedullary actions in the sheep fetus. The Journal of Physiology. 2003; 547, 283-291.
30. Thakor AS, Richter HG, Kane AD, et al. Redox modulation of the fetal cardiovascular defence to hypoxaemia. J Physiol. 2010; 588, 4235-4247.
31. Thakor AS, Herrera EA, Serón-Ferré M, Giussani DA. Melatonin and vitamin C increase umbilical blood flow via nitric oxide-dependent mechanisms. J Pineal Res. 2010; 49, 399-406.
32. Kane AD, Herrera EA, Hansell JA, Giussani DA. Statin treatment depresses the fetal defence to acute hypoxia via increasing nitric oxide bioavailability. J Physiol. 2012; 590(Pt 2), 323-334.
33. Herrera EA, Kane AD, Hansell JA, et al. A role for xanthine oxidase in the control of fetal cardiovascular function in late gestation sheep. J Physiol. 2012; 590(Pt 8), 1825-1837.
34. Kamitomo M, Alonso JG, Okai T, Longo LD, Gilbert RD. Effects of long-term, high-altitude hypoxemia on ovine fetal cardiac output and blood flow distribution. Am J Obstet Gynecol. 1993; 169, 701-707.
35. Richardson BS, Bocking AD. Metabolic and circulatory adaptations to chronic hypoxia in the fetus. Comp Biochem Physiol A MolIntegr Physiol. 1998; 119, 717-723.
36. Morrison J. Sheep models of intrauterine growth restriction: fetal adaptations and consequences. Clin Exp Pharmacol Physiol. 2008; 35, 730-743.
37. McMillen IC, Adams MB, Ross JT, Coulter CL, et al. Fetal growth restriction: adaptations and consequences. Reproduction. 2001; 122, 195-204.
38. Bertram CE, Hanson MA. Animal models and programming of metabolic syndrome. Br Med Bull. 2001; 60, 103-121.
39. Louey S, Cock ML, Harding R. Postnatal development of arterial pressure: influence of the intrauterine environment. Arch Physiol Biochem. 2003; 111, 53-60.
40. Armitage JA, Khan IY, Taylor PD, Nathanielsz PW, Poston L. Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals? J Physiol. 2004; 561, 355-377.
41. Langley-Evans SC, Bellinger L, McMullen S. Animal models of programming: early life influences on appetite and feeding behaviour. Matern Child Nutr. 2005; 1, 142-148.
42. Ruijtenbeek K, le Noble FAC, Janssen GMJ, et al. Chronic hypoxia stimulates periarterial sympathetic nerve development in chicken embryo. Circulation. 2000; 102, 2892-2897.
43. Miller SL, Green LR, Peebles DM, Hanson MA, Blanco CE. Effects of chronic hypoxia and protein malnutrition on growth in the developing chick. Am J Obstet Gynecol. 2002; 186, 261-267.
44. Rouwet EV, Tintu AN, Schellings MW, et al. Hypoxia induces aortic hypertrophic growth, left ventricular dysfunction, and sympathetic hyperinnervation of peripheral arteries in the chick embryo. Circulation. 2002; 105, 2791-2796.
45. Ruijtenbeek K, Kessels LC, De Mey JG, Blanco CE. Chronic moderate hypoxia and protein malnutrition both induce growth retardation, but have distinct effects on arterial endothelium-dependent reactivity in the chicken embryo. Pediatr Res. 2003; 53, 573-579.
46. Villamor E, Kessels CG, Ruijtenbeek K, et al. Chronic in ovo hypoxia decreases pulmonary arterial contractile reactivity and induces biventricular cardiac enlargement in the chicken embryo. Am J Physiol Regul Integr Comp Physiol. 2004; 287, R642-R651.
47. Sharma SK, Lucitti JL, Nordman C, et al. Impact of hypoxia on early chick embryo growth and cardiovascular function. Pediatr Res. 2006; 59, 116-120.
48. Tintu AN, Noble FA, Rouwet EV. Hypoxia disturbs fetal hemodynamics and growth. Endothelium. 2007; 14, 353-360.
49. Giussani DA, Salinas CE, Villena M, Blanco CE. The role of oxygen in prenatal growth: studies in the chick embryo. J Physiol. 2007; 585(Pt 3), 911-917.
50. Tintu A, Rouwet E, Verlohren S, et al. Hypoxia induces dilated cardiomyopathy in the chick embryo: mechanism, intervention, and long-term consequences. PLoS One. 2009; 4, e5155.
51. Lindgren I, Altimiras J. Chronic prenatal hypoxia sensitizes beta-adrenoceptors in the embryonic heart but causes postnatal desensitization. Am J Physiol Regul Integr Comp Physiol. 2009; 297, R258-R264.
52. Salinas CE, Blanco CE, Villena M, et al. Cardiac and vascular disease prior to hatching in chick embryos incubated at high altitude. J DOHaD. 2010; 1, 60-66.
53. Lindgren I, Altimiras J. Sensitivity of organ growth to chronically low oxygen levels during incubation in Red Junglefowl and domesticated chicken breeds. Poult Sci. 2011; 90, 126-135.
54. Jacobs R, Robinson JS, Owens JA, Falconer J, Webster ME. The effect of prolonged hypobaric hypoxia on growth of fetal sheep. J Dev Physiol. 1988; 10, 97-112.
55. Thompson JA, Richardson BS, Gagnon R, Regnault TR. Chronic intrauterine hypoxia interferes with aortic development in the late gestation ovine fetus. J Physiol. 2011; 589(Pt 13), 3319-3332.
56. Alonso JG, Okai T, Longo LD, Gilbert RD. Cardiac function during long-term hypoxemia in fetal sheep. Am J Physiol. 1989; 257(Pt 2), H581-H589.
57. Kamitomo M, Longo LD, Gilbert RD. Right and left ventricular function in fetal sheep exposed to long-term highaltitude hypoxemia. Am J Physiol. 1992; 262(Pt 2), H399-H405.
58. Kamitomo M, Longo LD, Gilbert RD. Cardiac function in fetal sheep during two weeks of hypoxemia. Am J Physiol. 1994; 266(Pt 2), R1778-R1785.
59. Browne VA, Stiffel VM, Pearce WJ, Longo LD, Gilbert RD. Activator calcium and myocardial contractility in fetal sheep exposed to long-term high-altitude hypoxia. Am J Physiol. 1997; 272(Pt 2), H1196-H1204.
60. Browne VA, Stiffel VM, Pearce WJ, Longo LD, Gilbert RD. Cardiac beta-adrenergic receptor function in fetal sheep exposed to long-term high-altitude hypoxemia. Am J Physiol. 1997; 273(Pt 2), R2022-R2031.
61. Gilbert RD. Fetal myocardial responses to long-term hypoxemia. Comp Biochem Physiol A Mol Integr Physiol. 1998; 119, 669-674.
62. Kamitomo M, Onishi J, Gutierrez I, Stiffel VM, Gilbert RD. Effects of long-term hypoxia and development on cardiac contractile proteins in fetal and adult sheep. J Soc Gynecol Investig. 2002; 9, 335-341.
63. Onishi J, Browne VA, Kono S, Stiffel VM, Gilbert RD. Effects of long-term high-altitude hypoxia and troponin I phosphorylation on cardiac myofilament calcium responses in fetal and nonpregnant sheep. J Soc Gynecol Investig. 2004; 11, 1-8.
64. Gilbert RD, Pearce WJ, Longo LD. Fetal cardiac and cerebrovascular acclimatization responses to high altitude, long-term hypoxia. High Alt Med Biol. 2003; 4, 203-213.
65. Kim YH, Veille JC, Cho MK, et al. Chronic hypoxia alters vasoconstrictive responses of femoral artery in the fetal sheep. J Korean Med Sci. 2005; 20, 13-19.
66. Camm EJ, Hansell JA, Kane AD, et al. Partial contributions of developmental hypoxia and undernutrition to prenatal alterations in somatic growth and cardiovascular structure and function. Am J Obstet Gynecol. 2010; 203, 495, e24-34.
67. Herrera EA, Camm EJ, Cross CM, et al. Morphological and functional alterations in the aorta of the chronically hypoxic fetal rat. J Vasc Res. 2012; 49, 50-58.
68. Thompson LP, Weiner CP. Effects of acute and chronic hypoxia on nitric oxide-mediated relaxation of fetal guinea pig arteries. Am J Obstet Gynecol. 1999; 181, 105-111.
69. Thompson LP, Aguan K, Pinkas G, Weiner CP. Chronic hypoxia increases the NO contribution of acetylcholine vasodilation of the fetal guinea pig heart. Am J Physiol Regul Integr Comp Physiol. 2000; 279, R1813-R1820.
70. Thompson LP. Effects of chronic hypoxia on fetal coronary responses. High Alt Med Biol. 2003; 4, 215-224.
71. Williams SJ, Campbell ME, McMillen IC, Davidge ST. Differential effects of maternal hypoxia or nutrient restriction on carotid and femoral vascular function in neonatal rats. Am J Physiol Regul Integr Comp Physiol. 2005; 288, R360-R367.
72. Williams SJ, Hemmings DG, Mitchell JM, McMillen IC, Davidge ST. Effects of maternal hypoxia or nutrient restriction during pregnancy on endothelial function in adult male rat offspring. J Physiol. 2005; 565(Pt 1), 125-135.
73. Hemmings DG, Williams SJ, Davidge ST. Increased myogenic tone in 7-month-old adult male but not female offspring from rat dams exposed to hypoxia during pregnancy. Am J Physiol Heart Circ Physiol. 2005; 289, H674-H682.
74. McEniery CM, Wilkinson IB. Large artery stiffness and inflammation. J Hum Hypertens. 2005; 19, 507-509.
75. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol. 1994; 140, 669-682.
76. Crispi F, Figueras F, Cruz-Lemini M, et al. Cardiovascular programming in children born small for gestational age and relationship with prenatal signs of severity. Am J Obstet Gynecol. 2012; 207, 121, e1-9.
77. Cruickshank K, Riste L, Anderson SG, et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002; 106, 2085-2090.
78. Skilton MR, Evans N, Griffiths KA, Harmer JA, Celermajer DS. Aortic wall thickness in newborns with intrauterine growth restriction. Lancet. 2005; 365, 1484-1486.
79. Koklu E, Kurtoglu S, Akcakus M, et al. Increased aortic intima-media thickness is related to lipid profile in newborns with intrauterine growth restriction. Horm Res. 2006; 65, 269-275.
80. Akira M, Yoshiyuki S. Placental circulation, fetal growth, and stiffness of the abdominal aorta in newborn infants. J Pediatr. 2006; 148, 49-53.
81. Cosmi E, Visentin S, Fanelli T, Mautone AJ, Zanardo V. Aortic intima media thickness in fetuses and children with intrauterine growth restriction. Obstet Gynecol. 2009; 114, 1109-1114.
82. Veille JC, Hanson R, Sivakoff M, Hoen H, Ben-Ami M. Fetal cardiac size in normal, intrauterine growth retarded, and diabetic pregnancies. Am J Perinatol. 1993; 10, 275-279.
83. Mayhew TM, Gregson C, Fagan DG. Ventricular myocardium in control and growth-retarded human fetuses: growth in different tissue compartments and variation with fetal weight, gestational age, and ventricle size. Hum Pathol. 1999; 30, 655-660.
84. Rizzo G, Capponi A, Rinaldo D, Arduini D, Romanini C. Ventricular ejection force in growth-retarded fetuses. Ultrasound Obstet Gynecol. 1995; 5, 247-255.
85. Miyague NI, Ghidini A, Fromberg R, Miyague LL. Alterations in ventricular filling in small-for-gestational-age fetuses. Fetal Diagn Ther. 1997; 12, 332-335.
86. Li G, Xiao Y, Estrella JL, et al. Effect of fetal hypoxia on heart susceptibility to ischemia and reperfusion injury in the adult rat. J Soc Gynecol Investig. 2003; 10, 265-274.
87. Li G, Bae S, Zhang L. Effect of prenatal hypoxia on heat stressmediated cardioprotection in adult rat heart. Am J Physiol Heart Circ Physiol. 2004; 286, H1712-H1719.
88. Xue Q, Zhang L. Prenatal hypoxia causes a sex-dependent increase in heart susceptibility to ischemia and reperfusion injury in adult male offspring: role of protein kinase C epsilon. J Pharmacol Exp Ther. 2009; 330, 624-632.
89. Patterson AJ, Chen M, Xue Q, Xiao D, Zhang L. Chronic prenatal hypoxia induces epigenetic programming of PKC{epsilon} gene repression in rat hearts. Circ Res. 2010; 107, 365-373.
90. Patterson AJ, Zhang L. Hypoxia and fetal heart development. Curr Mol Med. 2010; 10, 653-666.
91. Xue Q, Dasgupta C, Chen M, Zhang L. Foetal hypoxia increases cardiac AT(2)R expression and subsequent vulnerability to adult ischaemic injury. Cardiovasc Res. 2011; 89, 300-308.
92. Patterson AJ, Xiao D, Xiong F, Dixon B, Zhang L. Hypoxiaderived oxidative stress mediates epigenetic repression of PKCe gene in foetal rat hearts. Cardiovasc Res. 2012; 93, 302-310.
93. Xu Y, Williams SJ, O'Brien D, Davidge ST. Hypoxia or nutrient restriction during pregnancy in rats leads to progressive cardiac remodeling and impairs postischemic recovery in adult male offspring. FASEB J. 2006; 20, 1251-1253.
94. Hauton D, Ousley V. Prenatal hypoxia induces increased cardiac contractility on a background of decreased capillary density. BMC Cardiovasc Disord. 2009; 9, 1.
95. Rueda-Clausen CF, Morton JS, Davidge ST. Effects of hypoxia-induced intrauterine growth restriction on cardiopulmonary structure and function during adulthood. Cardiovasc Res. 2009; 81, 713-722.
96. Rueda-Clausen CF, Morton JS, Lopaschuk GD, Davidge ST. Long-term effects of intrauterine growth restriction on cardiac metabolism and susceptibility to ischaemia/reperfusion. Cardiovasc Res. 2011; 90, 285-294.
97. Rueda-Clausen CF, Morton JS, Dolinsky VW, Dyck JR, Davidge ST. Synergistic effects of prenatal hypoxia and postnatal high-fat diet in the development of cardiovascular pathology in young rats. Am J Physiol Regul Integr Comp Physiol. 2012; 303, R418-R426.
98. Hauton D. Hypoxia in early pregnancy induces cardiac dysfunction in adult offspring of Rattus norvegicus, a nonhypoxia-adapted species. Comp Biochem Physiol A Mol Integr Physiol. 2012; 163, 278-285.
99. Giussani DA, Camm EJ, Niu Y, et al. Developmental programming of cardiovascular dysfunction by prenatal hypoxia and oxidative stress. PLoS One. 2012; 7, e31017.
100. Salem R, Denault AY, Couture P, et al. Left ventricular enddiastolic pressure is a predictor of mortality in cardiac surgery independently of left ventricular ejection fraction. Br J Anaesth. 2006; 97, 292-297.
101. Danson EJ, Li D, Wang L, Dawson TA, Paterson DJ. Targeting cardiac sympatho-vagal imbalance using gene transfer of nitric oxide synthase. J Mol Cell Cardiol. 2009; 46, 482-489.
102. Bristow MR. Beta-adrenergic receptor blockade in chronic heart failure. Circulation. 2002; 101, 558-569.
103. Ream M, Ray AM, Chandra R, Chikaraishi DM. Early fetal hypoxia leads to growth restriction and myocardial thinning. Am J Physiol Regul Integr Comp Physiol. 2008; 295, R583-R595.
104. Ruijtenbeek K, Kessels CG, Janssen BJ, et al. Chronic moderate hypoxia during in ovo development alters arterial reactivity in chickens. Pflugers Arch. 2003; 447, 158-167.
105. Am J Physiol Regul Integr Comp Phy
106. Morton JS, Rueda-Clausen CF, Davidge ST. Mechanisms of endothelium-dependent vasodilation in male and female, young and aged offspring born growth restricted. Am J Physiol Regul Integr Comp Physiol. 2010; 298, R930-R938.
107. Morton JS, Rueda-Clausen CF, Davidge ST. Flow-mediated vasodilation is impaired in adult rat offspring exposed to prenatal hypoxia. J Appl Physiol. 2011; 110, 1073-1082.
108. Leeson CP, Whincup PH, Cook DG, et al. Flow-mediated dilation in 9-to 11-year-old children: the influence of intrauterine and childhood factors. Circulation. 1997; 96, 2233-2238.
109. Leeson CP, Kattenhorn M, Morley R, Lucas A, Deanfield JE. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation. 2001; 103, 1264-1268.
110. Camm EJ, Martin-Gronert MS, Wright NL, et al. Prenatal hypoxia independent of undernutrition promotes molecular markers of insulin resistance in adult offspring. FASEB J. 2011; 25, 420-427.
111. Rueda-Clausen CF, Dolinsky VW, Morton JS, et al. Hypoxia-induced intrauterine growth restriction increases the susceptibility of rats to high-fat diet-induced metabolic syndrome. Diabetes. 2011; 60, 507-516.
112. Dolinsky VW, Rueda-Clausen CF, Morton JS, Davidge ST, Dyck JRB. Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in offspring born growth restricted. Diabetes. 2011; 60, 2274-2284.
113. Nuyt AM. Mechanisms underlying developmental programming of elevated blood pressure and vascular dysfunction: evidence from human studies and experimental animal models. Clin Sci (Lond). 2008; 114, 1-17.
114. Davidge ST, Morton JS, Rueda-Clausen CF. Oxygen and perinatal origins of adulthood diseases: is oxidative stress the unifying element? Hypertension. 2008; 52, 808-810.
115. Thompson LP, Al-Hasan Y. Impact of oxidative stress in fetal programming. J Pregnancy. 2012; 2012, 582748.
116. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 2004. Oxford University Press: Oxford, UK.
117. Xiong F, Xiao D, Zhang L. Norepinephrine causes epigenetic repression of PKCe gene in rodent hearts by activating Nox1-dependent reactive oxygen species production. FASEB J. 2012; 26, 2753-2763.
118. Hashimoto K, Pinkas G, Evans L, et al. Protective effect of N-acetylcysteine on liver damage during chronic intrauterine hypoxia in fetal guinea pig. Reprod Sci. 2012; 19, 1001-1009.
119. Parraguez VH, Atlagich M, Araneda O, et al. Effects of antioxidant vitamins on newborn and placental traits in gestations at high altitude: comparative study in high and low altitude native sheep. Reprod Fertil Dev. 2011; 23, 285-296.
120. Richter HG, Camm EJ, Modi BN, et al. Ascorbate prevents placental oxidative stress and enhances birth weight in hypoxic pregnancy in rats. J Physiol. 2012; 590(Pt 6), 1377-1387.
121. Bourque SL, Dolinsky VW, Dyck JR, Davidge ST. Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia. Placenta. 2012; 33, 449-452.
122. Richter HG, Hansell JA, Raut S, Giussani DA. Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. J Pineal Res. 2009; 46, 357-364.
123. Lemley CO, Meyer AM, Camacho LE, et al. Melatonin supplementation alters uteroplacental hemodynamics and fetal development in an ovine model of intrauterine growth restriction. Am J Physiol Regul Integr Comp Physiol. 2012; 302, R454-R467.
124. Stanley JL, Andersson IJ, Poudel R, et al. Sildenafil citrate rescues fetal growth in the catechol-O-methyl transferase knockout mouse model. Hypertension. 2012; 59, 1021-1028.
125. Stanley JL, Andersson IJ, Hirt CJ, et al. Effect of the antioxidant tempol on fetal growth in a mouse model of fetal growth restriction. Biol Reprod. 2012; 87, 251-258.
126. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews Drug Discovery. 2006; 5, 493-506.
127. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006; 444, 337-342.
128. Niu Y, Allison BJ, Kane AD, et al. Intergenerational inheritance of cardiovascular disease risk induced by chronic fetal hypoxia. Society for Gynecologic Investigation, 60th Annual Scientific Meeting, March 20-23, 2013, Orlando, FL, USA.